Insilico Medicine
Insilico Medicine is a clinical-stage biotechnology company applying generative AI and robotic automation to drug discovery and development. Its Pharma.AI software suite includes PandaOmics (target discovery from multi-omics data), Chemistry42 (generative chemistry with retrosynthesis, property prediction, and ADMET), Generative Biologics, inClinico (clinical trial outcome prediction), Science42 DORA (research assistant), Nach01, and PreciousGPT-family models for life sciences. The company runs its own therapeutic pipeline spanning oncology, fibrosis, and inflammation, with programs targeting TNIK, USP1, QPCTL, PHD, MAT2A, TEAD, ENPP1, KAT6 and others through Phase II. Insilico monetizes through Pharma.AI software licensing, partnerships with major pharmaceutical companies, and progression of its in-house assets. Pharma.AI tools are commercial SaaS products accessed via web UI; the company publishes open-source research code on GitHub (GENTRL, fcd_torch, BiAAE, DD-VAE, DORA) but does not expose a public commercial API.
Index entry only — little beyond a description and a link, and nothing machine-readable enough for an agent to act on without a human reading the site first.
API Evangelist profiles Insilico Medicine the way a machine reads it — 1 machine-readable artifact, pulled from the provider's own public surface and indexed so a developer, an analyst, or an AI agent can evaluate it against every other provider on the network.
Every provider in the network is reduced to the same set of machine-readable artifacts — OpenAPI contracts, event specifications, GraphQL schemas, runnable collections, pricing and rate-limit signals, security posture, OAuth scopes, and the agent surfaces (MCP servers and skills) that let software drive the API on its own. We profile them because the interface is the part of a company you can actually inspect: it is a truer signal of what a provider does than any marketing page. From those artifacts we compute the Kin Score — Insilico Medicine scores 7.9/100 (minimal), with a separate agent-readiness read of 0/100 (human only). The full breakdown is below, followed by every artifact we hold — each card links through to its machine-readable definition on apis.io.
Kin Score
This is the API Evangelist rating — a single, repeatable read computed from the artifacts on this page. Green fill is points earned; the red track is points possible, so every bar shows earned-versus-possible at a glance.
Kin Score
How this is scored →scored 2026-07-27 · rubric v0.5
How we profile Insilico Medicine
Each block below is one kind of artifact we hold for Insilico Medicine. For each we say what it is and why it earns a place in the profile, then list every one we've indexed — capped at two rows, scroll within the panel for the rest.
Security Posture 1
Authentication, domain security, vulnerability disclosure, and trust-center signals — the evidence that a provider takes security seriously enough to document it. We profile it because you can't govern what you can't see.
Authentication, domain security, vulnerability disclosure, and trust-center signals.
Resources
Every other property we hold for Insilico Medicine — documentation, portals, status pages, policies, and corporate surface — grouped by the job it does, following the integrator's arc from getting started to running in production.
Build 1
SDKs, sample code, and the tooling you integrate with
Access & Security 1
Authentication, authorization, and security posture
Operate 1
Status, limits, changes, and where to get help
Company 7
The organization behind the API
Scroll within the panel for all 7 ·
Other 4
Properties that don't map to a standard resource type
← All providers · Data indexed from github.com/api-evangelist/insilico-medicine · machine-readable index on apis.io